Pharmacogenomics in the Era of Next Generation Sequencing – from Byte to Bedside-Reference-Cited by-同舟云学术

Pharmacogenomics in the Era of Next Generation Sequencing – from Byte to Bedside

Published:2021-04-05 Issue: Volume: Page:1-79
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Russell Laura E.¹,Zhou Yitian²,Almousa Ahmed A.³,Sodhi Jasleen K.⁴,Nwabufo Chukwunonso K.⁵,Lauschke Volker M.²

Affiliation:

1. Theravance Biopharma US, Inc., 901 Gateway Blvd, South San Francisco, CA, 94080, USA

2. Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden

3. Department of Pharmacy, Victoria Hospital, London Health Sciences Center, 800 Commissioners Rd E, London, ON N6A 5W9, Canada

4. Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco, San Francisco, CA, USA

5. Gilead Alberta ULC, Edmonton, AB, T6S 1A1, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2021.1909613

Reference213 articles.

1. 1Table of Pharmacogenomic Biomarkers in Drug Labeling. FDA. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling [Accessed 06.02.2021].

2. Young, J., Bhattacharya, K., Ramachandran, S., Lee, A. & Bentley, J. P. Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling. The Pharmacogenomics Journal 319, 2379-2378 (2021).

3. Sim, S. C., Kacevska, M. & Ingelman-Sundberg, M. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. The Pharmacogenomics Journal 13, 1-11 (2013).

4. Clarke, J. D. & Cherrington, N. J. Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions. Expert Opinion on Drug Metabolism & Toxicology 8, 349-360 (2012).

5. Davies, E. A. & O’Mahony, M. S. Adverse drug reactions in special populations - the elderly. British Journal of Clinical Pharmacology 80, 796-807 (2015).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene-environment interactions within a precision environmental health framework;Cell Genomics;2024-07

2. Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice;Pharmacogenetics and Genomics;2024-06-18

3. Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System;Pharmaceutics;2024-02-19

4. Next-generation sequencing in pharmacogenomics – fit for clinical decision support?;Expert Review of Clinical Pharmacology;2024-01-23

5. Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward;Annual Review of Pharmacology and Toxicology;2024-01-23